Showing results (241-250 of 254) with videos related to
Sort By:
Pageof 26
Diagnostic Microbiology and Infectious Disease|February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countriesJoseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.Journal of the International Association of Providers of AIDS Care|December 23, 2024
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in CameroonCollins Ambe Chenwi, Rachel Audrey Nayang Mundo, Alex Durand Nka, et al.Journal of Clinical Laboratory Analysis|February 2, 2026
Diagnostic Concordance of Two- and Three-Gene SARS-CoV-2 Molecular Assays in Cameroon: Implications for Efficient Pandemic Response in Low- and Middle-Income CountriesAurelie Minelle Kengni Ngueko, Sandrine Claire Djupsa Ndjeyep, Ezechiel Ngoufack Jagni Semengue, et al.PLOS Global Public Health|March 19, 2025
Disparities in anti-SARS-CoV-2 reactivity according to vaccines administered in the era of omicron in Cameroon: Lessons for future outbreak responseEzechiel Ngoufack Jagni Semengue, Desire Takou, Marina Potesta, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapiesVelia C Di Maio, Valeria Cento, Ilaria Lenci, et al.Viruses|November 24, 2022
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in ItalyAlessia Lai, Annalisa Bergna, Carla Della Ventura, et al.Medicine|May 19, 2025
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in CameroonYagai Bouba, Aude Christelle Ka'e, Davy-Hyacinthe Anguechia Gouissi, et al.PLOS Global Public Health|May 15, 2026
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countriesYagai Bouba, Aude Christelle Ka'e, Cynthia Ayafor, et al.AIDS Research and Therapy|December 9, 2025
Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in CameroonNadine Nguendjoung Fainguem, Yagai Bouba, Rachel Kamgaing, et al.Plos Medicine|September 22, 2023
Recommendations on data sharing in HIV drug resistance researchSeth C Inzaule, Mark J Siedner, Susan J Little, et al.Pageof 26